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3 Preface  
Since the Norwegian Registry for Spine Surgery (NORSpine) was started in 2007, more than 50000 
patients operated for lumbar spinal degenerative disorders have been included. The registry was 
started in Tromsø by my mentor Dr. Solberg, and has since spread out to all public and private 
clinics in the country. Similar registries have been developed in Europe[1], and the United States[2], 
collecting large amounts of data. However, use of this data at the hospitals is scarce, and while 
positive effects of quality registries have been shown in some medical disciplines[3], so far there is 
little evidence for spine registries having an impact on clinical practice. This thesis is aimed at 
bridging this gap by developing a decision support tool that conveys information from the 
NORspine about those previously operated back to patients and physicians, so that they can make 





This thesis is the brainchild of my mentor Tore Solberg, one of the founding fathers of the 
NORspine. Tore, with your positive and encouraging attitude it was easy for you to win me over for 
this project, and with your bottomless supply of coffee and patience you kept me going until this 
point. Thanks for your big brain, humor, the writing sessions during late night on calls, the meetings 
and conferences, and the occasional bottle of wine. Without you, this would have never happened.  
I also owe my gratitude to Margreth and Milada, who in countless sessions have with the utmost 
patience managed to hammer basic statistics into a surgeon’s brain. Without you, these papers 
would never have materialized. Thanks for the highly productive meetings in your small office in 
Oslo Margreth, and for the midnight answering service in regards to statistical technicalities 
Milada. Thank you, Sasha for your unwavering positive attitude, no matter what manuscripts I 
threw at you, and for the good brainstorming during meetings and conferences. Øystein, thanks for 
the golden nuggets of tips and insight, and for staying awake during your long Nepal flights to 
review my manuscripts. Ivar, thanks for taking the time to contribute to this work, whilst you very 
much where busy with your own PhD. Thanks also to Øyvind, who solved some very important 
methodological problems in the final steps of this work. 
To all my colleagues at the Neurosurgical Department in Tromsø, thanks for supporting me when I 
needed to take time off clinical work to write papers, and for tolerating my constant bickering 
about this work. Lars, my roomie for more than six years, we have had all the ups and downs young 
neurosurgeons can experience during their training. Lasse, thanks for being my clinical supervisor 
and close friends during all this time. Kay, Jens, Andreas, and Tore, thanks for your valuable insights 
9 
 
into spine surgery, and for the countless hours in and out of theater discussing treatment 
approaches and surgical technique. Lasse, Roar, Jørgen, and Kristin thanks for training me in 
intracranial surgery, and being able to consult with you not matter what time of day. Roar and 
Kristin, thanks so much for giving med the administrative leeway to make this project possible, and 
for redirecting clinical workflow in order to get me all the time I needed to cross the finish line. To 
all my fellow residents, Helene, Maria, Kaja, Fanny, Daniel, and all the others over the last six years 
thanks for being flexible so that I could take the occasional short notice meeting, on call rotation or 
project-related trip. 
Needless to say, without the unwavering support from the two most important persons in my life, I 
would have never made it this far, neither with this project, nor in my job. Thanks to Kristina and 







I am very grateful for the financial support for this project received through research grants from 
both the Regional Health Authority of Northern Norway (Helse Nord) and the Norwegian Medical 
Association (Legeforeningen). Their support made it possible for me to take time off intermittently 




6 List of papers 
 
I. Werner DAT, Grotle M, Gulati S, Austevoll IM, Lønne G, Nygaard ØP, Solberg TK (2016) 
Criteria for failure and worsening after surgery for lumbar disc herniation: a 
multicenter observational study based on data from the Norwegian Registry for Spine 
Surgery. Eur Spine J [Internet]. 2017; Available from: 
http://link.springer.com/10.1007/s00586-017-5185- 
 
II. Werner DAT, Grotle M, Gulati S, Austevoll IM, Madsbu MA, Lønne G, Solberg TK (2019) 
Can a successful outcome after surgery for lumbar disc herniation be defined by the 
Oswestry disability index raw score? Glob Spine J [Internet]. 2019;219256821985148. 
Available from: http://journals.sagepub.com/doi/10.1177/2192568219851480 
 
III. Werner DAT, Grotle M, Gulati S, Salvesen Ø, Nygaard ØP, Ingebrigtsen T, Solberg TK 
(2020) A prognostic model for failure and worsening one year after lumbar 
microdiscectomy. A multicenter observational study based on the Norwegian Registry 






AI   Artificial Intelligence 
ANCOVA  Analysis of Covariance 
ANOVA  Analysis of Variance 
AUC  Area Under the Curve 
CI   Confidence Interval 
EQ-5D  EuroQol 5 Dimensions 
GPE  Global Perceived Effectiveness 
L1-5  Lumbar level 1-5 
MCIC  Minimal Clinical Important Change 
MRI  Magnetic Resonance Imaging 
NORspine  Norwegian Registry for Spine Surgery 
NRS  Numerical Rating Scale 
ODI  Oswestry Disability Index 
PASS  Patient Acceptable Symptom State 
PROM  Patient Reported Outcome Measure 
RCT  Randomized Controlled Trial 
ROC  Receiver Operating Curve 
SD   Standard Deviation 
SDC  Smallest Detectable Change 
SEM  Standard Error of Measurement 
VAS  Visual Analogue Scale 
13 
 
7 What is this thesis about? 
 
7.1 Overall aim 
The overall aim of this research work was to develop a clinical tool which would be used by both 
surgeons and patients to predict outcome 12 months after lumbar microdiscectomy. With an 
outcome prediction the patient and surgeon would then be able to make an evidence-based 
informed decision about the question whether to operate or not. It is important to note that this 
thesis does not concern non-operative treatment of lumbar disc herniation. 
7.2 Outcome definition 
In order to be able to predict an outcome, first it must be clearly defined. This was the aim of 
papers I and II, where we defined criteria for success, failure and worsening 12 months after 
microdiscectomy for lumbar disc herniation, based on different Patient Reported Outcome 
Measures (PROMs). Notably we chose to define these criteria based on much larger magnitude of 
PROM changes, than the previously defined Minimal Clinical Important Change (MCIC). 
7.3 Outcome prediction 
With established outcome criteria, we developed a predictive tool by utilizing known risk factors 
and patient characteristics in paper III. The resulting model was implemented into a risk matrix, 
with an algorithm allowing us to calculate the probability of a negative outcome after surgery. 
7.4 Structure 
In the introduction, I will outline the clinical entity of lumbar disc herniation. Further, I will 
introduce clinical quality registries, and on this background introduce the metric of a PROM and 
how treatment outcomes are assessed with this tool. I will then briefly discuss the imperative of 
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quality assessment in modern medicine, and the of role prognostic research in its context. Since the 
papers are closely related, the methodological section, results, discussion and conclusion will 






8.1 Lumbar disc herniation 
8.1.1 Anatomy 
The spine or vertebral column is made up of bony building blocks (vertebrae) which are connected 
by intervertebral discs made up of a collagenous perimeter (annulus fibrosus) containing a liquid 
rich mucoprotein gel (nucleus pulposus), and by facet joints and ligaments. Behind the lumbar 
vertebrae and the intervertebral disc runs a bundle of nerve roots, covered by a layer of connective 
tissue (dura mater). A bony lamina is attached to each side of the vertebral body by the pedicles. 
This bony arch, the facet joints, and the yellow ligament (ligamentum flavum) protect the spinal 
cord from posterior. Thereby the spinal cord is run through a protective bony “tunnel” giving off 
one nerve root on each side at each vertebra of the spine. The lumbar spine denotes the last five 
vertebrae (L1-L5) making up the lower back, before the tail bone (sacrum and coccygeus). 
Approximately at the level of L1 the spinal cord ends. Below the dural sac contains peripheral 
nerves, i.e. the L1-L5, as well as the sacral 1-5 nerve roots, and collectively termed the “cauda 
equina” due to its resemblance of the tail of a horse[4]. The nerve roots exit the spinal canal by the 
foramen, defined by the pedicle above, the intervertebral disc medially, and the facet joint and 
isthmus laterally and below. 
8.1.2 Pathophysiology 
The degenerative process of the spine (spondylosis) increases with age, and starts in the 
intervertebral disc. Weakening or rupture of the annulus fibrosus can lead to herniation of the 
nucleus pulposus and impingement of  nerve root(s) against the wall bony walls of the spinal canal 
or foramen[5]. Mechanical compression and inflammation can lead to pain and neurological 
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deficits, such as loss of both sensory and motor function according to the innervation of the 
affected nerve root. This radiculopathy manifests as radiating pain down the leg, and potentially 
numbness on the thigh, calf and areas of the foot[6–11]. In the case of lumbar disc herniation, the 
4th and 5th disc are most commonly affected. The sum of these symptoms can be highly invalidating 
for the patient[12,13]. While the cause of a disc herniation is not entirely clear, both age, 
environmental, and genetic factors are suspected[14–17]. 
8.1.3 Epidemiology 
The lifetime prevalence of lumbosacral radiculopathy is estimated to be between 12-27%. While 
the symptoms clear with the spontaneous resorption of the disc herniation in the majority of 
patients, surgery for lumbar disc herniation is the most common spinal surgical intervention[18–





Lumbar disc herniation causes radiculopathy and leg pain. In addition, back pain is often be 
present. However, leg pain worse than back pain carries a high sensitivity for lumbar disc 
herniation[12]. The pain is often mechanical, i.e. increasing upon coughing, sneezing or lifting. 
Sensory loss for light touch, pain, and temperature can be present in the area known to be 
innervated by a given nerve root. Physical examination can show a mechanically irritable nerve root 
by maneuvers stretching the femoral or sciatic nerve (ipsilateral straight leg or inverted leg raising 
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test). Motor testing can reveal a paresis in muscle groups innervated by the given nerve root, as 
well as impaired reflex arcs innervated by the given root. In late stages of the disorder muscle 
wasting can be seen[12,23]. 
Imaging 
Magnetic Resonance Imaging (MRI) is the gold standard for diagnosing intervertebral disc 
herniations[24]. A magnetic field is used to excite water molecules from their natural state and 
then to measure signals given off by these molecules upon returning to their resting state. This 
type of imaging is well suited to depict water rich anatomical structures, such as the nucleus 
pulposus and the contents of the dural sac. MRI for lumbar disc herniation has a sensitivity and 
specificity of 81% and 77%[25]. 
It is important to note that not all disc herniations with nerve impingement necessary lead to 
symptoms. Disc herniations can be found in 30-40% of asymptomatic individuals, increasing by 




In 70% of cases a herniated disc will dry out and shrink spontaneously within 3 - 12months, leading 
to a spontaneous improvement in symptoms[28]. Conservative regimens usually include rest, non-
steroidal anti-inflammatory agents, and in some cases opiates and/or neuropathic pain 
medications. There is no clear evidence as to the benefit of surgical treatment over conservative 
approaches 12-24 months after onset of symptoms. Still, patients undergoing initial conservative 
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treatment will experience longer duration of pain, physical impairment, and sick leave than 
patients undergoing surgery within the first 6-12 weeks[19,29].  
Surgical 
In Norway and Europe microscope assisted discectomy (microdiscectomy) is the gold standard for 
surgical treatment of lumbar disc herniation. The procedure is performed under general 
anesthesia, with the patient in prone or knee/elbow position[30,31]. A 3-4cm incision is made 
between the two spinous processes above and below the affected disc. The thoracolumbar fascia is 
opened near the midline, and the underlying rectus muscle is dissected away from the lamina of 
the two vertebrae in a subperiosteal fashion. A retractor instrument is then placed so that the 
interspace between the two laminae is visualized. With the visual assistance of an operating 
microscope or loupes, the ligamentum flavum is opened and the underlying thecal sac and the 
affected nerve root are identified. Depending on the location of the disc herniation, the root is 
medialized or lateralized and the underlying posterior longitudinal ligament might be opened and 
the disc material is extracted.  
Open discectomy was the most commonly used surgical method before the general advent of 
microscopes and it is rarely used nowadays. The procedure requires a larger incision and may lead 
to more soft tissue trauma, and may require more removal of more bone to improve 
visualization[32]. In contrast, use of the microscope allowed for minimal incision size with 
improved lightning and visualization. 
In a minimal invasive discectomy, in a small tube is placed into the interlaminar space through av 1-
2 cm incision. By use of an endoscope the thecal sac and nerve root are visualized, and the 
19 
 
herniated disc material is then removed in a similar fashion as in a microdiscectomy. While this 
procedure requires an even smaller skin incision, it requires additional instruments, yet the 
evidence is not clear on whether this procedure leads to superior outcome[33,34]. 
Nonsurgical invasive methods such as chemonucleosis[35], thermal nucleotomy[36] and epidural 
steroid injections[7,37] may be used as an alternative to surgical management. Evaluation of these 
methods is beyond the scope of this thesis. 
Treatment decision 
Lumbar disc herniations can in rare cases cause severe symptoms, also known as cauda equina or 
conus syndrome[38]. In these cases several nerve-roots are affected leading to sensation loss in the 
perineum and loss of bladder and external anal sphincter control, as well as paresis in the lower 
extremities. More commonly, nerve-root compression can cause loss of motor function, leaving the 
patient with a limp. Progressive neural deficits due to a lumbar disc herniation require an urgent 
decompression of the nerve-root, and thus they are considered absolute indications for 
surgery[39–41]. Radicular pain alone or in conjunction with back pain due to a disc herniation is a 
relative indication for surgery. This applies to cases were the nerve root compression does not 
naturally resolve, or where the pain is so invalidating that non-surgical treatment approaches yield 
no acceptable quality of life for the patient[19,29]. Since the indication for surgery is relative in 
most cases, it is important that the possibilities for both favorable and unfavorable outcome are 
discussed between patient and surgeon. In the Norwegian Registry for Spine Surgery (NORspine) 
20% of cases are operated for paresis, and 1.3% for cauda equina. Thus about 80% are operated for 
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pain alone. It is therefore imperative that the treatment decision is based on the best available 




8.2 Clinical registry 
8.2.1 Definition 
A clinical registry is defined as an organized system for the collection, storage, retrieval, analysis, 
and dissemination of information on individual persons who have a particular disease […][44]. 
8.2.2 Purpose 
Registry based research is aimed at  improving the quality of health care in daily clinical 
practice[45]. The goal is to evaluate how treatments work in everyday clinical practice, when 
surgeons and patients have chosen a given type of treatment according to preferences. In contrast,  
randomized controlled trials (RCTs), intend to evaluate if treatment can work in idealized 
“homogenous” conditions[46]. While RCTs have high internal validity, they lack external validity, 
i.e. how does a given treatment perform in the “heterogenous” real life world of medical practice. 
In the latter, personal preferences of both patients and physicians, heterogenous comorbidities 
and lifestyle factors, as well as shortcuts in treatments and non-compliance introduce factors 
influencing the outcome[46,47]. 
8.2.3 Design 
Clinical registries are designed a priori, collecting data based on a predefined purpose, i.e. quality in 
assessment and research. Unlike clinical trials with predefined patient management protocols, 
clinical registries “shadow” patient evaluation, treatment, and follow-up without influencing the 
course of these steps. This also means that data collection is prospective according to the general 
purpose of the registry at predefined time points, as opposed to data being collected 
retrospectively from other data sources such as the patient record[44]. 
22 
 
8.3 Outcome interpretation 
 
Modern day healthcare is based on scientific evidence. This evidence should weigh the patient’s 
perspective on treatment and outcomes, as well as taking into account costs[48]. In order to 
measure outcome after interventions for multifactorial pain conditions such as degenerative spinal 
disorders, patient centered outcome measures have gained popularity and are now considered to 
be a gold standard[49,50]. 
8.3.1 Patient Reported Outcome Measures (PROMs) 
In 1978 Lee et.al.[51] noted in a paper about surgery for spinal stenosis, that objective clinical 
findings did not reflect the patient’s functional outcome. They thus proposed a self-rated 
questionnaire allowing the patient to score his/her functional abilities for several domains of daily 
living, laying the fundament for PROMs in spine care[52]. Since then, PROMs have become the gold 
standard outcome measure in spine care, and their use has increased exponentially[53,54].  
PROMs can be defined as “any report of the status of a patient’s health condition that comes 
directly from the patient, without interpretation of the patient’s response by a clinician or anyone 
else”[55]. PROMs can be measured in absolute terms, or as a change from a previous measure[56]. 
They let patients themselves report symptom intensity and functional impairment by answering 
specific questions, such as what type of chair they can sit in, or by grading symptom level, e.g. by a 
Visual Analogue Scale (VAS) for pain intensity. Answers to these questions are subsequently 
converted into a point score depicting the patient’s functional level and quality of life as dictated by 
symptom burden. PROMs intend to answer questions regarding quality of care, such as “does the 
given treatment work?” and “does the patient perceive the treatment effect as expected by the 
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caregiver?”[57]. These constructs became popular quickly, because they allowed for a patient 
centered evaluation of treatment outcomes, shifting away from metrics like imaging diagnostics or 
biased caregiver opinion[53].  
The most commonly used PROM in spine care, aside of the general VAS, is the Oswestry Disability 
Index (ODI) which asks the patient 10 questions regarding the limitations of daily life activities. Each 
answer is translated into a 0 to 5-point score, and consequently transferred into a percentage score 
with a range of 0 (no disability) to 100 (maximum pain related disability). The ODI is a specific 
PROM used in degenerative spinal conditions. The current version, employed in this study, is the 
ODI v 2.1a[58].  
A generic health-related quality of life assessment is the EuroQol-5D (EQ5D 3L), evaluating the five 
dimensions of mobility, self-care, pain, anxiety, and activities of daily living. The degree of problems 
the patient has in each dimension is rated as either none, mild-to-moderate, or severe. These 
answers are translated into a score range from -0.59 to 1, where 1 corresponds to perfect health 
and 0 to death. Notably, negative values are considered to be worse than death. The EQ-5D has 
been validated for spine care[59].  
Pain-ratings can either be recorded by the VAS, or more simply by a Numeric Rating Scale (NRS) 
ranging from 0 to 10, where 0 equals no pain and 10 the worst pain imaginable[60]. 
The Norwegian version of the PROMs measured in the NORspine and used for this study can be 




8.3.2 Minimal Clinical Important Change (MCIC) 
With the advent of clinical registries and the increasing popularity of PROMs, a new problem 
became apparent. Because clinical registries allow for collection and evaluation of much larger data 
sample than traditional RCTs, small differences in measured data points could potentially be 
statistically significant, yet meaningless in the clinical context[57]. In order to overcome this issue, 
the MCIC, or minimal important difference (MID), or minimal important change (MIC) was 
introduced in 1989[61], and defined as the smallest change in outcome that a patient perceives as 
clinically important[62]. In the current body of literature, the a clinical important change is mainly 
determined based on two approaches, namely an anchor based method or a distribution based 
method, the smallest detectable change (SDC)[57,62,63]. 
 
Anchor based 
As the name implies, in the anchor-based approach a PROM cut-off for the MCIC is determined by 
comparing (anchoring) PROM scores to an overall rating of the treatment effect by either the 
patient or physician. The Global Perceived Effectiveness (GPE) scale is such a rating tool, asking the 
patient to score the perceived treatment effect on a scale from 1 to 7, where 1 is the best possible 
outcome, and 7 the worst[64]. Average PROM changes between each category of this anchor can 
then be calculated and serve as descriptions of treatment effect. The GPE has good test retest 






The SDC is a statistical approach to measuring the smallest relevant change that can be detected 
mathematically through the noise (distribution) of the data. The SDC is calculated based on 
standard error of measurement (SEM), or the standard deviation (SD)[57,62]. In short if the 
magnitude of the PROM change reaches a certain level of baseline SD, for example ½ the SD, this 
change is determined to carry a clinical significance. The SDC should ideally not be greater than the 
MCIC. 
 
8.3.3 Substantial clinical change 
It is important to distinguish the minimal perceived change of the MCIC from substantial clinical 
effects. While a treatment effect in the magnitude of the MCIC might be perceivable by the patient, 
it might not be the patients or practitioners’ goal of the intervention. A substantial clinical change 
based on PROMs, is one that exceeds the threshold of the MCIC by a good margin. This type of 
treatment effect is not merely perceived as clinically meaningful (e.g. feeling a little better), but 
rather perceived as a significant change in clinical status (e.g. feeling much better, or feeling 
completely recovered)[66,67]. While changes in the dimension of the MCIC are useful e.g. for 
sample size calculation in RCTs, substantial clinical changes are making the biggest difference for 
both the patient and practitioner in real life clinical practice, and thus need to be aspired to in 
order to improve quality of care[67–69]. As part of this dissertation I will propose outcome criteria 




8.4 Outcome prediction 
A physician essentially has three tasks, namely to diagnose a condition and its etiology, foresee the 
prognosis, and to treat based on the best current medical standards. While etiological and 
therapeutic research is receiving widespread attention, the field of prognostic research has been 
the most limited of the three. Prognosis does not simply inform about the expected course of an 
illness or a treatment. Prognostic research also intends to estimate the risk of future outcomes in 
individuals based on their clinical and socio-demographic characteristics[70]. Clinical registries open 
new possibilities for prognostic studies using a multivariable approach to predict outcome 
probabilities based on numerous patient and disease specific parameters. These studies result in so 
called predictive or prognostic models, estimating an absolute risk or probability for a given 
outcome[71]. A prominent example is the Framingham study for predicting the 10-year mortality 
due to a cardiovascular event, based on given risk factors[72]. 
It is important to distinguish between prognostic modelling and associative modelling. While a 
prognostic model aims solely at predicting a future outcome with the highest possible accuracy, an 
associative model aims to identify  independent risk factors for an outcome, while adjusting for 
other possible causal factors[71]. 
Development of a predictive model should optimally be performed in the setting of a prospective 
cohort study containing generalizable data from patients with heterogenic risk profiles, as well as a 
long period of follow-up, as opposed to a RCT with small sample sizes, and very comparable 




8.5 Quality of care 
The Institute of Medicine defines quality in healthcare as the “degree to which health services [..] 
increase the likelihood of desired outcomes and are consistent with current professional 
knowledge”[74]. Contributing to quality are the informed participation of the patient, attention to 
the scientific basis of treatment and the efficient use of resources. With the advent of PROMs, the 
results of care can be evaluated with greater scientific accuracy, and according to the patient’s own 
experience. At the same time indications, risk factors, complication- and outcome measurements 
are collected in large clinical registries, such as the NORspine. These data allow assessment of 
quality of care for the given collecting hospital, or region, and make benchmarking and comparison 
between different medical facilities possible[75]. Consequently, medical professionals now are 
compelled to utilize this evidence in order to improve and maintain the quality of care, yet so far 
spine registries have had limited impact on the quality of spine care[76]. 
In the field of surgery for lumbar disc herniation the indication for surgery is often relative, yet 
patient expectations exceed those in other fields of surgery for degenerative conditions[77]. 
Treatment decisions must be derived from the balance between possible benefits, risks and also 
costs[48]. In a setting of increasing number of spinal surgical interventions, avoiding inefficient 
surgeries might have a larger impact on treatment outcomes, than improving the surgical 
technique itself[22,78,79]. Just as Thomas Mroz stated in his note[48] on the advent of value based 




9 Materials and Methods 
 
9.1 Design 
This work is a prospective multicenter observational cohort study of patients operated with lumbar 
microdiscectomy over the period January 1st, 2007 and August 2nd 2015. 
9.2 Data source 
The NORspine collects data on patients operated for degenerative disorders of the spine associated 
to spondylosis and spondylarthrosis, such as lumbar disc herniation, lumbar spinal stenosis, 
degenerative or isthmic spondylolisthesis, and degenerative scoliosis and segmental back pain. 
Both emergency and elective surgeries are recorded[80]. 
The registry does not include patients fulfilling the following criteria: 
• Patients unable to give informed consent due to cognitive deficits or reduced consciousness 
• Children < 16 years 
• Patients with serious drug abuse or severe psychiatric disorders 
• Patients with fractures, primary infections or malignant conditions in the spine 
• Patients unable to respond to the declaration of consent and/or the questionnaires due to 
language barriers 





9.3 Study population 
All patients were recruited from the NORspine over the period of 2007 to 2015. During the study 
period the registry had a coverage (proportion of spinal centers reporting to the registry) of 95% of 
all public and private institutions, and a completeness (proportion of operated patients reported to 
the registry) of 65%[43].  
For the purpose of this study, we excluded all patients operated on for any other conditions than 
lumbar disc herniation and/or patients who underwent fusion procedures. After subsequent 
exclusion of cases lost to follow-up, as well as patients diagnosed with spondylolisthesis, a total of 
11081 cases were used in the analyses. In paper I and II a smaller patient sample (6840 cases) was 
created following these steps. In paper III the material was split at random into a training sample 
(70% of cases) and validation sample (30% of cases). This was done to allow for building the 
prognostic model in the training sample, and validate it in the smaller validation sample[81]. 
9.4 Data collection 
Patients included in the registry filled out a questionnaire collecting baseline data on 
demographics, lifestyle issues, and PROMs at admission for surgery (baseline). During the hospital 
stay the surgeon recorded data concerning diagnosis, treatment, and comorbidities on a standard 
registration form. Twelve months after surgery a questionnaire identical to that used at baseline 
was distributed by regular mail. It was completed at home by the patients and returned to the 
central registry unit without involvement of the treating hospitals. One reminder with a new copy 
of the questionnaire was sent to those who did not respond. A copy of both questionnaires is 




Baseline characteristics were compared between responders and non-responders at 12 months 
follow-up. Outcome differences were investigated between elective and emergent lumbar 
microdiscectomies. We then investigated the correlation of four PROMs, namely the ODI, EQ-5D, 
NRS back pain and NRS leg pain with the GPE, 12 months after surgery. Furthermore, we assessed 
variation in postoperative scores for these PROMs between the individual GPE categories. We 
consequently defined two different outcome types, “failure” and “worsening”, based on GPE 
categories. We then calculated cut-off points for both the change score, the percentage change 
score (except for the EQ-5D), and the final raw score for each PROM against the two outcome types 
12 months after surgery. The PROM showing the highest accuracy was selected and cut-off values 
were entered as the dependent variable in regression models, with patient baseline characteristics 
as possible independent predictors. Based on the regression models we finally created a risk matrix 
calculating the risk for a given outcome in percent. 
9.6 Statistics 
All statistical analyses were performed with either SPSS (IBM, Version 23.0), or R (Version 2.13.1). 
In paper I we assessed the variance of PROM scores against the seven categories of the GPE with 
and without adjustment for the baseline ODI, by means of analysis of variance (ANOVA) and 
analysis of covariance (ANCOVA). For nominally distributed data we assessed correlation between 
the PROMs and the GPE by Spearman rank correlation, and for non-nominal data (ODI raw score) 
Pearson correlation was used. In papers I and III differences in baseline characteristics for patients 
lost to follow-up versus completed follow-up were investigated by independent sample t-tests 
(continuous variables) and chi square tests (categorical variables). Furthermore, we compared 
outcome after 12 months between emergency and elective cases, by an independent sample t-test 
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for the PROMs and by Mann-Whitney U test for the GPE. In both papers I and II we calculated cut-
off values for the respective PROMs (in paper II only the ODI was used), by using the coordinates of 
Receiver Operating Curves (ROC) that showed the highest sensitivity and specificity for classifying a 
given outcome. Overall classification rates of the PROM cut-offs against the actual outcomes were 
identified by confusion matrices[82]. In paper III we identified potential risk factors for both failure 
and worsening by univariate binary logistic regression. Significant variables were consequently 
included in a binary logistic multiple regression model, and removed in a backwards manual fashion 
based on their level of significance. Goodness of predictions were analyzed by plotting the 
observed proportion of outcome against the average predicted proportion. Chi square test was 
used to assess if there were significant differences between the predicted and observed 
coordinates on the graph (calibration)[83]. The discriminative ability (discrimination) was 
determined by running ROC analyses of the risk values against the predicted outcome, where the 
area under the curve (AUC) served as an estimate for the accuracy (C-criterion)[84].  
9.7 Ethical considerations 
This study is based on data collected from clinical cases. No animals, drugs, human tissue or other 
live tissue samples were part of this investigation. The study protocol was submitted to the regional 
ethical committee for medical research which categorized it as a clinical audit study, not in need of 
their formal approval[85]. Participation in the registry is neither mandatory, nor required to receive 
treatment. Except for data registration, no differences in treatment decision and hospital protocol 
are done for patients participating in the registry or those who opt out. All patients are offered an 






10.1 Outcome definition (Paper I and II) 
ANOVA showed that both the mean ODI, EQ-5D, NRS back-pain, and NRS leg-pain scores were 
significantly different between GPE groups 1-3 and 4, as well as GPE groups 4,5 and 6,7. We defined 
“failure” as a patient rated outcome of GPE 4 – 7 (no change, somewhat worse, much worse, worse 
than ever), and “worsening” as a patient rated outcome of GPE 6-7 (much worse, worse than ever). 
All PROMs correlated significantly with the GPE. For none of the PROMs were floor or ceiling 
effects found. The ODI percentage change, as well as the 12-months ODI raw score, were the most 
robust in defining failure and worsening. Initially we identified cut-offs for the whole study 
population (table 1). The overall correct classification rates were highest for the ODI raw and the 
ODI percentage change scores, however only the ODI raw score 12 months after surgery showed 
acceptable accuracy when defining failure or worsening. 
During the analyses we noticed that the cut-offs are dependent on the level of baseline disability 
and we additionally calculated failure/worsening cut-offs on the ODI score for three baseline ODI 
groups, namely patients with low baseline disability (ODI <33, <25th percentile), moderate baseline 
disability (ODI 33-58, 25th-75th percentile), and high baseline disability (ODI >58, >75th percentile).  
We also identified an ODI raw cut-off for success (GPE groups 1 and 2), for all three baseline ODI 
groups (table 2). Again, the ODI raw and ODI percentage change scores were the most accurate for 
defining the outcome.  
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Based on our cut-offs, 63-65% of patients had a successful outcome 12 months after 




Table 1. PROM cut-offs for failure and worsening, for the entire study population. 
 Failure  Worsening 
Cut-
off 





Sens/Spec AUC (95% CI) Corr. 
Class 
% 
ODI        
Change score 13 0.82, 0.82 0.89 (0.88 - 0.91) 82  
Percentage 
change score 
33 0.86, 0.86 0.93 (0.92 - 0.94) 
 
86  
12 month raw 
score 
25 0.89, 0.81 0.92 (0.91 - 0.93) 86  48 0.70, 0.70 0.76 (0.72 - 0.80) 69 
NRS leg-pain        
Change score 1.5 0.81, 0.76 0.87 (0.86 - 0.88) 84  
Percentage 
change score 
39 0.86, 0.81 0.89 (0.88 - 0.90) 84  
12 month raw 
score 
4.5 0.91, 0.85 0.90 (0.88 - 0.91) 84  7.5 0.64, 0.68 0.70 (0.66 - 0.75) 67 
NRS back-pain 
 
      
Change score 1.5 0.74, 0.86 0.85 (0.84 - 0.86) 76  
Percentage 
change score 
24 0.85, 0.81 0.87 (0.86 - 0.88) 86  
12 month raw 
score 
5.5 0.81, 0.87 0.92 (0.91 - 0.93) 86  7.5 0.78, 0.64 0.77 (0.73 - 0.81) 68 
EQ-5D1 
 
      
Change score 0.10 0.76, 0.83 0.85 (0.84 - 0.87) 82  
12 month raw 
score 
0.63 0.81, 0.85 0.91 (0.90 - 0.92) 85  0.09 0.76, 0.60 0.71 (0.67 - 0.75) 65 
 
Cut-offs were calculated for the four different PROMs against the GPE by means of ROC analyses. All cut-off 
values with corresponding sensitivity and specificity, area under the curve (95% confidence interval) and 
percentage of correctly classified. For worsening, only the 12-month raw scores were used, all other cut-offs 






Table 2. Baseline dependent cut-offs for success. 
 










<25th percentile 0.92 0.90-0.93 13 0.81/0.88 83 
25-75th percentile 0.95 0.94-0.95 21 0.85/0.89 86 
>75th percentile 0.94 0.93-0.96 28 0.89/0.85 88 
 
ODI change 
    
ODI Prescore AUC CI Cut-off sens/spec Accuracy 
(%) 
<25th percentile 0.89 0.88-0.91 9 0.77/0.84 79 
25-75th percentile 0.92 0.91-0.93 24 0.83/0.84 83 
>75th percentile 0.92 0.91-0.94 48 0.85/0.84 85 
 ODI % 
change 
    
ODI Prescore AUC CI Cut-off sens/spec Accuracy 
(%) 
<25th percentile 0.91 0.90-0.93 39 0.82/0.84 83 
25-75th percentile 0.94 0.94-0.95 53 0.86/0.88 86 
>75th percentile 0.94 0.93-0.96 66 0.85/0.88 88 
 
Cut-offs were calculated for three ODI metrics, the change score, the % change score, and the 12-months ODI 
raw score, by means of ROC analyses. AUC = Area Under the Curve, CI = 95% Confidence Interval, sens = 





10.2 Outcome prediction (Paper III) 
Based on the results in papers I and II we chose the ODI raw score at 12-months as the PROM 
which cut-offs should be predicted for both failure and worsening. Depending on the level of 
baseline disability (preoperative ODI) we split the study population into three groups, namely those 
with a baseline ODI below the 25th percentile, above the 75th percentile, and in between the 25th 
and 75th percentile. We built one model for both failure and worsening in each group. Based on the 
results from the uni- and multivariate regression analyses, each model resulted in three risk 
matrices, with 7-11 different covariates. Smoking, an educational level with less than four years of 
college or university education, and the presence of more than 12 months of back pain prior to 
surgery were significant risk factors common to all six matrices. Discriminative ability of the model 
was acceptable, but calibration testing showed that the matrix predicting worsening in the high ODI 
baseline group (ODI >58) deviated significantly (p<0.1) from the optimal prediction line (Fig 1), 




Observed proportion of the outcome (with confidence interval) on the vertical axis against average predicted probability of the outcome on the horizontal axis. 
Each coordinate with whiskers represents one quartile of estimated probability and its 95% confidence interval, compared to the observed proportion of the 
predicted outcome. The p-value from the chi square test for the coordinates vs the optimal prediction line is indicated in the lower right corner. A p-value < 
0.1 indicates significant deviation from the average predicted probability. A-C show prediction of failure for the three baseline invalidity groups (A: Baseline 
ODI <25th percentile, B 25-75th percentile, C >75th percentile). D-F show prediction of worsening for the three baseline invalidity groups (D: Baseline ODI 
<25th percentile, E: 25th – 75th percentile, F: >75th percentile). 
Figure 1 Model validation 
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Figure 2. Prediction model for failure or worsening. 
 
Model algorithm for the three ODI baseline groups. Based on the preoperative ODI the patient will be 
classified via one of the three pathways, calculating an overall risk for either failure or worsening. Risk is 
calculated from the odds of each risk factor. The risk factors are listed in random order, and their place in 
the sequence does not reflect their odds. 1Range: 0-100 (no-maximal disability). The ODI score was <33, 
33-58 and >58 in the subgroups with low, medium high baseline disability, respectively.2Less than four 
years of college/university education. 3Body Mass Index ≥30. 4EQ-5D 3L questionnaire; 5th item, moderate 
to severe problems. 5Pending medical claim/ litigation the Norwegian public welfare agency fund concerning 
disability pension. 6Numeric Rating Scale (0-10). 7American Society of Anesthesiologists grade 8Pending 
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medical compensation claim/litigation against private insurance companies or the public Norwegian System 






11.1 Main finding 
The main finding of this thesis is that we were able to develop a prognostic model for failure 
and worsening 12 months after lumbar microdiscectomy, based on data from the Norwegian 
registry for spine surgery. We also found that unfavorable outcome can readily be defined by 
cut-offs on the ODI, NRS backpain, NRS legpain, and EQ-5D. The ODI percentage change, and 
the final ODI score 12 months after surgery were the most accurate PROMs for this purpose. 
The final ODI score after 12 months was also able to define a favorable outcome after surgery 
with high accuracy. Furthermore, cut-offs for all metrics, were depending on the amount of 
preoperative baseline disability.  
11.2 Outcome definition 
 
11.2.1 Advantages and disadvantages of PROMs 
Since their inception, PROMs have gained in popularity due to several advantages. They allow 
for measuring the impact of chronic pain conditions such as disability, symptom burden, and 
quality of life from the patients’ own perspective, whereby eliminating observer bias (no 
surgeons rating of the outcome). Moreover, they facilitate communication and shared decision 
making. Since they assess domains important to the patient, they also increase self-
awareness[52,54,56,86].  
While PROMs offer significant advantages, they also bear some inherent problems. Since they 
are based on the patient’s own assessment, and often are measured prior to and after a given 
intervention, they are susceptible to the lapsing memory (recall bias) and change in the 
patients’ value construct (response shift). Recall bias simply implies that a patient does not 
remember his or her rating on a given dimension of the PROM, e.g. how badly the symptom 
 
41 
intensity was 12 months ago[87]. Response shift basically implies a change in the patient’s 
perspective of the PROM items. Response shift can be further classified into recalibration 
(change in internal standard of the patients assessment of his/her wellbeing), reprioritization 
(the same items of health related quality of life do not carry the same weight in the patient’s 
own perception of quality of life), and reconceptualization (redefinition of the concept)[88]. In 
addition, PROMs can exhibit floor or ceiling effects, where the potential disability could extend 
beyond the scale leading to a grouping of patients who might consider their disability levels 
differently[89,90]. 
11.2.2 Choosing the right anchor 
When choosing an anchor for establishing cut-offs of clinical significance against the PROMs, 
this anchor should be intuitively meaningful, able to inform on the change over time, as well as 
reflect the PROM`s concept[91]. Ideally it should also be objective, easy to measure, and 
applicable in all kinds of clinical settings. Yet no such anchor exists. 
The GPE is based on the patient’s ability to recall hers/his symptom state 12 months earlier, and 
compare it to the symptom state at the time of the assessment. Both assessments, the previous 
and the current, are potentially biased in the same way as PROMs, and as explained in the 
previous chapter. The ability to remember the level of symptoms and disability varies from 
patient to patient, and some might not recall accurately how they felt before the surgery (recall 
bias)[65]. Furthermore, when assessing the symptom state at the time of follow-up, other 
factors than pain and disability might influence the patients rating of his or her overall health, 
and thereby potentially influencing the rating of the outcome on the GPE scale (response 
shift)[57,92]. Patient expectations and their discrepancy to the actual outcome can also 
influence the overall rating of surgery[77,93]. Other measurements have been suggested, such 
as the clinicians rating of outcome, which has been proven to differ from the patients 
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perspective [52,94]. More objective measures such as return to work, painkiller use, or other 
group specific metrics exclude subgroups of patients and are more difficult to measure.  
To the best of my knowledge, the GPE is currently the most optimal approximation to a gold 
standard anchor. This is also reflected in the recommendations of the Food and Drug 
Administration (FDA) and IMMPACT consensus group[49,50]. 
11.2.3 Failure and worsening 
In chronic pain conditions, any surgery resulting in no improvement or even worse symptoms 
after the surgery, can hardly be viewed as beneficial. Outcome constructs defining positive 
results after surgical interventions on the spine have previously been evaluated[67], and 
clearance of all symptoms naturally leads to an outcome being rated as successful. We aimed at 
defining the negative spectrum of outcome after lumbar microdiscectomy, and we chose two 
categories, namely failure and worsening. In paper I ANOVA analyses of the ODI against the GPE 
showed that GPE categories 1-3 (completely recovered, much better, somewhat better) were 
significantly different from category 4 (no change) (fig. 3). Furthermore, categories 4-5 (no 
change, slightly worse) and 6-7 (much worse, worse than ever) were clearly distinguishable. We 
therefore decided to define one outcome class as failure, where the patient reported no change 
or a worse status 12 months after surgery. We also defined a category where the patient 
reported at least a much worse outcome after surgery, termed worsening. A large proportion 
(24%) of patients classified themselves as somewhat better, unchanged, or somewhat worse 
after surgery, based on the GPE. However, those in the somewhat better group showed a mean 
improvement on the ODI over 15 points, which crosses the threshold of the MCIC[95]. Thus, 







Figure 3. Analysis of variance (ANOVA) 
 
Analysis of variance (ANOVA) of the mean final ODI raw score 12 months after lumbar microdiscectomy 
against the Global Perceived Effectiveness scale (GPE) ranging from 1 – completely recovered, to 7 – 




11.2.4 ODI superiority and final score versus change score 
In paper I ROC analyses showed that the ODI was superior to the NRS back-pain, NRS leg-pain, 
and the EQ-5D when determining a cut-off for both failure and worsening. This is not surprising 
since ODI is both a disease specific metric, as it takes in account more than one dimension of 
pain. Thus, it is also from a clinical perspective more suitable, than e.g. the NRS leg-pain[67,96]. 
It has been previously validated for the Norwegian population[97], and in our studies we could 
not identify floor or ceiling effects. 
In both papers I and II we could see that the ODI change score in points clearly had inferior 
measurement properties than the ODI raw score, or the ODI percentage score for defining 
outcomes cut-offs. This has also been shown in a large medical registry study in the US[98], as 
well as for a lumbar spinal stenosis study in the NORspine[99], and makes sense as the change 
in points does not reflect the underlying magnitude of improvement or worsening (i.e. a patient 
improving 30 points with a baseline ODI of 40 experienced a much larger improvement than a 
patient with a baseline ODI of 70). Our results also confirm the notion that the final ODI score is 
of importance when the patient rates his or her outcome after 12 months[65]. Symptoms may 
well have improved from baseline, yet the patient might consider the outcome as failed, or even 
worsened. Figure 4 shows how patients who actually experienced improvements from their 
baseline ODI, report outcome scores indicating that they feel unchanged or even worse after 
the surgery. This illustrates the importance of a disability score as the entity defining failure or 
worsening (or positive outcomes on the other end of the scale), versus simply using the patient 
rated outcome, or even the surgeon’s own opinion. Furthermore, this implies that change alone 
is not the sole arbiter of a substantial benefit to the patient, and that the final ODI score plays a 
role in the patients’ perceived benefit of the surgery. This is also a finding of other studies, 




11.2.5 The impact of baseline disability 
ROC analyses in papers I and II show that all cut-offs for the ODI, independent of metric, differ 
based on the preoperative ODI score. Patients with a larger amount of disability need to 
perceive a larger amount of improvement, not only in points but also in percent, in order to rate 
the surgery not as failure or worsening. This is in accordance with a similar study[98]. 
Consequently, the baseline ODI needs to be controlled for, when developing outcome criteria 
and prognostic models. One simply cannot apply the same criteria for a patient with a rather 
low baseline disability, vs a patient on the high end of the spectrum. 
11.2.6  Limitations of the minimal clinical important difference 
The MCIC has previously been recommended as an outcome criterion for success after spine 
surgery[62]. This is somewhat problematic as the MCIC is a fluid construct[101], proven to be 
shifting in magnitude based on the amount of baseline disability a patient experiences before 
surgery, as well as the time passed since the surgery[52]. Many patients might experience 
change corresponding to the MCIC, and yet rate their outcome negatively. This is illustrated in 
figure 4, where the yellow diagonal line represents a change of 15 points in the ODI between 
baseline and 12 months after lumbar microdiscectomy. This line delineates the generally 
accepted MCIC for the ODI[95]. All points to the right of that line have achieved a postoperative 




Figure 4. The Minimal Clinical Important Difference (MCIC) versus the cut-offs 
for failure and worsening on the final ODI raw score 
 
Y axis: ODI raw score at 12 months vs X axis: ODI at baseline. The blue diagonal line represents no 
change. The yellow diagonal line represents the MCIC of 15 points. Coordinates to the right of the yellow 
line represent patients who have achieved the MCIC 12 months after microdiscectomy. The red line 
indicates the 12-month ODI raw cut-off, above which patients consider themselves as worse, irrespective of 





We suggest that stronger criteria, such as success or failure/worsening are to be used when one 
wishes to improve quality of care, instead of minimal changes such as the MCIC. Rather than 
drawing conclusions in regard to outcome and their implications in terms of clinical significance, 
the MCIC can be used when comparing outcome across groups or interventions. 
Aside of questions around the clinical implication, neither the MCIC or metrics of larger 
amplitude such as the substantial clinical change take into account the cost of treatment. This 
might not matter to the patient, but very much to the legislator, administrator, politician, and 
society, who in the future might want to see value for their money in terms of clinical effect 
achieved per unit currency spent[47,101].  
11.3 Outcome prediction 
In paper III we developed a prognostic model resulting in six risk matrices predicting negative 
outcome (failure/worsening) 12 months after surgery for lumbar disc herniation. Each matrix is 
applicable to a baseline ODI range (<25th, 25th-75th, or >75th baseline ODI percentile). It is 
important to note that the model was built based on data from a population of patients who 
were all referred to surgery, and had undergone lumbar microdiscectomy. Thus, the model 
might not be applicable for patients who are evaluated in general practice and who might 
benefit from noninvasive treatment options. Furthermore, the model was built based on patient 
data from the NORspine, and thus usability and feasibility in other spine registries needs to be 
assessed.  
11.3.1 Creating a prognostic model 
In prognostic modelling, especially in the field of medicine, two main methods are used. The 
traditional approach is multivariable analysis, while the more novel approach is based on 
artificial neural networks[102]. The discussion of the latter is beyond the scope of this 
dissertation. Multivariable analysis determines contributions of various factors to a single 
outcome. It’s a powerful tool which can be utilized for different purposes, mainly to either shed 
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light on the importance of each individual factor in regards to the outcome (used in 
epidemiological, associative studies), or to predict a given outcome based on the presence or 
absence of risk factors and possibly unknown secondary factors (confounders). The latter 
method is used for prognostic modelling and is the method of choice for this dissertation.  
Due to the nature of the majority of variables collected in the NORspine, we chose logistic 
regression where the included covariates are dichotomous (yes or no). This allows for the 
calculation of odds ratios (OR), from which probabilities can be calculated. The advantage of this 
is that the concept of a probability for a given outcome is easy to understand for both patient 
and clinical caretaker, as opposed to coefficient values from linear logistic regression models. 
However, dichotomization also bears disadvantages. Information from continuous observations 
is lost, and patients are pooled into categories leading to the same outcome prediction, albeit 
having potentially different risk values. Dichotomization also hampers comparability with other 
studies on the same subject, using different cut-off points on the linear scales[103].  
While associative models are sensitive for confounders, prognostic models make no 
assumptions in their regard[104]. Thus, based on our analyses we cannot make an assumption 
on the causal relationship between smoking and the outcome after lumbar microdiscectomy. 
Our model shows that smoking increases the risk for failure and worsening as an outcome after 
lumbar disc surgery. While smoking might directly have an impact on the outcome, its effect 
might very well be mediated by a known or unknown confounder. 
When building a multiple regression model, one can choose between an automatic or manual 
approach, and in case of the latter between a forward, backward, or subset method. Automatic 
methods act non-discretionally based solely on mathematical reasoning. While this approach is 
criticized due to issues with confounding in associative modelling, it is also not optimal for 
predictive models. This is due to the fact that in some cases clinically important variables are 
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excluded in favor of other variables just because of a minor difference in mathematical 
statistical significance. Manual models have the advantage of clinical discretion and better 
transparency. For our purpose we chose manual backward regression. We first made a 
preselection of variables by univariate regression, assessing the predictive power of each 
covariate on its own against the outcome. Significant variables were consequently entered in 
the model simultaneously, and then the weakest one was excluded until only statistically 
significant variables remained[84]. Based on clinical discretion we also included age and gender, 
irrespective of statistical significance. Because previous findings indicated that the rating of the 
outcome 12 months after surgery is strongly influenced by the amount of baseline disability 
based on the ODI score, we chose to create subset models for three baseline strata, resulting in 
the six risk matrices.  
Once a model is built and risk matrices calculate the probability for a given outcome, the 
question is as to the accuracy of said predicion. In the case of logistic regression, a 
recommended method is to compare the proportion of predicted risk to observed outcome in 
groups of patients, i.e. in a group of 100 patients averaging a 30% predicted probability of a 
given outcome, optimally 30 patients should achieve this outcome[84]. Our results illustrate this 
assessment in figure 2. The reader may note that the 95% CIs are larger for the three matrices 
predicting worsening, indicating a smaller sample size. This represents a weakness in the 
models, resulting from a rather low incidence of worsening as an outcome 12 months after 
surgery. Nevertheless, aside of the matrix predicting worsening in those with a baseline ODI 
above the 75th percentile, observed proportions of outcome did not deviate significantly from 
the average predicted probability. It is important to note though, that this might only hold true 
for our study population and that the model`s reliability might be insufficient when evaluated in 




11.3.2 Choice of risk factors 
 
When developing a prognostic model, one has to make a choice in regards to which risk factors 
to include in order to predict the given outcome. Simply including any factor available in the 
dataset would lead to the best accuracy for the given model applied in the data set it was 
developed from, and while that is well within the purview of a prognostic regression model, this 
approach would hamper its generalizability to other clinical registries and its applicability in 
clinical practice. In order to develop a both clinically meaningful and generalizable prediction 
model, risk factors included should be readily available, simple to measure, and at the same 
time carry a high predictive value. Based on these criteria, we chose covariates which have 
previously been identified, such as intensity of low back pain and leg pain, BMI, educational 
level, previous back surgery, smoking, and unresolved issues with disability funds or medical 
insurances[106,107,116–119,108–115]. While all operated patients had an MRI confirmed 
lumbar disc herniation, the registry does not collect data on prolapse morphology. This might be 






11.4 Handling of missing data 
 
We report a lost to follow-up rate at 12 months of 31-32% in our papers. Among non-
respondents we found a statistically significant higher proportion of risk factors for a negative 
outcome in patients that smoke, have a lower educational level, have had previous lumbar disc 
surgery, and those receiving sickness or disability payments. At the same time these cases also 
showed a higher proportion of positive risk factors, as in they were younger, more likely to be 
men, suffering from less comorbidities, and had less severe limb paresis. Still, loss to follow-up 
could represent a selection bias, if these cases would show a significant difference in outcome 
against our study population[122,123]. This issue has been addressed not only in the 
Norwegian, but also the Swedish and Danish spine registries, where patients lost to follow-up 
were traced and interviewed. The studies found the same baseline differences when comparing 
responders to non-responders, yet no differences in outcome between the two groups up to 24 
months after surgery[124–126]. 
Aside of missing outcome data for those lost to follow-up, we reported low percentage of 
missing data for baseline values in all PROMs. The largest proportion of missing data in all three 
studies was found in paper III, where the BMI as a possible risk factor had approximately 10% of 
datapoints missing. Based on the results from the studies mentioned above, we deleted missing 
data in a pairwise fashion. In longitudinal studies one has the option to estimate values of 
missing data by different methods of imputation, namely cross sectional or longitudinal 
imputation. In regards of outcome data lost to follow-up, a popular method is imputation by 
carrying the last known observation forward to the end-point. Carrying forward 3-month follow-
up values of the ODI to estimate 12-month outcomes is not advised[127,128]. The NORspine 
does not register outcome values between these two timepoints, thus more advanced 
longitudinal methods cannot be applied here. When handling missing baseline values, cross 
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sectional imputation could be applied by taking the mean of either all available values for a 
given variable (mean of series imputation), or the mean of a random set of cases with similar 
baseline characteristics for a given variable. Another, more sophisticated, method is building a 
prognostic model predicting a given baseline variable, based on the presence of other baseline 
variables. The main author considered the first two methods to be guessing at best. The last 
method was not considered, as predicting BMI based on other socioeconomic variables 
potentially carried significant bias in itself, and goes far beyond the scope of this study. For this 
reason, cross sectional regression is only advised for missing outcome variables but should not 
be applied to estimate predictor variables. It has also been shown that imputation of missing 
data has no significant impact on the final models with 10% missing values at baseline. 
Furthermore, imputation of missing data of larger proportion led to weakening of the regression 
models[129]. 
Instead of trying to estimate missing values, we rather recommend to use data from the whole 
study population in order to calibrate the prognostic models, and subsequently assess 
applicability and discriminative ability in another study population, such as in another spine 
registry. 
11.5 Model application 
The prediction model developed in paper III is based on data from patients who already have 
undergone lumbar microdiscectomy. Thus, these patients have prior been selected as suitable 
candidates for surgery by either a neurosurgeon, or an orthopedic surgeon. The model is aimed 
at aiding the surgeon and the patient in the shared decision-making process, especially when 
the grounds for a surgical indication are weak or uncertain. Furthermore, the predicted 
outcome can be helpful in setting expectation levels prior to surgery.  
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12 Future Perspectives 
 
Spine care is an expensive business, and regulators are voicing the need for a value-based 
approach[130,131]. Spine care patients are a heterogenous population, with varying levels of 
expectations and means to cope with pain. There is a need to make personalized informed 
decisions about a surgical treatment the outcome of which cannot be measured by means of 
survival rates, but is so very important for the quality of life[132]. This work represents the first 
step in predicting outcome after a common surgical intervention for a chronic pain condition in 
a heterogenous patient group, on a large scale. I hope that our model can be externally 
validated in another spine registry population, and consequently be the platform for a risk 
calculator to be tested in clinical practice. A possible scenario would be to compare differences 
in practice and outcome between two units, where one is applying the calculator during the 
surgeon/patient shared decision-making process. If proven useful, similar concepts can be 
applied in decision processes for surgical treatment of other degenerative disorders. 
Novel, artificial intelligence (AI) driven prediction of outcomes, is increasingly gaining ground 
also in the field of neurosurgery[133,134]. We expect these techniques to take a central part in 
medical decision making in the future, also in the field of surgical indication judgement. It will 
be interesting to see if an AI can handle the complex interaction of risk factors better than a 







In this dissertation we have analyzed data on patients operated for lumbar disc herniation by 
means of lumbar microdiscectomy. Patient participation in the studies, by partaking in the 
NORspine registry, has not led to additional examinations or deviation of treatment protocol 
from regular clinical practice. We defined cut-off values on validated PROMs to classify 
outcomes as “success”, “failure”, and “worsening”. The ODI percentage change, and the final 
ODI score 12-months after lumbar microdiscectomy were the most accurate in defining these 
outcomes.  As the result of our analyses, we propose a prognostic model for two outcomes, 
namely failure and worsening, one year after surgery for lumbar disc herniation. The model is 
built based on previously identified risk factors, and outcome criteria identified based on the 
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Table 1x. Proportion of cases classified as success after 12 months for different groups of baseline 
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